FibroScan–aspartate aminotransferase score in an Asian cohort of non‐alcoholic fatty liver disease and its utility in predicting histological resolution with bariatric surgery

Abstract

FibroScan-aspartate aminotransferase score demonstrated good discrimination for fibrotic non-alcoholic steatohepatitis in our cohort. However, a miscalibration resulted in overprediction. The score correlated well with the histological response to interventions for NAFLD.